Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
2002
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
2013 StandoutNobel
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads
2012 StandoutScience
UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells
2002
Signal Transduction Inhibition of APCs Diminishes Th17 and Th1 Responses in Experimental Autoimmune Encephalomyelitis
2009
2F1 antigen, the mouse homolog of the rat “mast cell function-associated antigen”, is a lectin-like type II transmembrane receptor expressed by natural killer cells
1998
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
2012
Crystal Structure of the Murine Cytomegalovirus MHC-I Homolog m144
2006
The promise of 4‐1BB (CD137)‐mediated immunomodulation and the immunotherapy of cancer
2008
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells
2000
Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis
2000 StandoutNature
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
2015
Neurexins Physically and Functionally Interact with GABAA Receptors
2010 StandoutNobel
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
1999
On guard—activating NK cell receptors
2001
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
A Novel Family of Inhibitory Receptors for HLA Class I Molecules That Modulate Function of Lymphoid and Myeloid Cells
1999
Exacerbated graft-versus-host disease in Pirb−/− mice
2004
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
The Story of Rett Syndrome: From Clinic to Neurobiology
2007
Specific recognition of virus‐infected cells by paired NK receptors
2004
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors
2005
Crystal Structure of the MHC Class I Homolog MIC-A, a γδ T Cell Ligand
1999
Murine Cytomegalovirus Homologues of Cellular Immunomodulatory Genes
1999
The role of immune dysfunction in the pathophysiology of autism
2011
Dendritic cells and tumor immunity
2001
Neurexin 1α structural variants associated with autism
2008
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer
1998
Metazoan MicroRNAs
2018 Standout
Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes
2004
ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
2001
The Inhibitory Receptor LIR-1 Uses a Common Binding Interaction to Recognize Class I MHC Molecules and the Viral Homolog UL18
1999
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
2000
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
2015
Activation, coactivation, and costimulation of resting human natural killer cells
2006
High Affinity Neurexin Binding to Cell Adhesion G-protein-coupled Receptor CIRL1/Latrophilin-1 Produces an Intercellular Adhesion Complex
2012 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Natural killer cells and viral infections
2003
Neuroligins and neurexins link synaptic function to cognitive disease
2008 StandoutNatureNobel
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors
2000
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
2003 StandoutNatureNobel
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
2000
Self-tolerance of natural killer cells
2006
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
1998
Protein Tyrosine Phosphatases in the Human Genome
2004 Standout
gp49B1-αvβ3 interaction inhibits antigen-induced mast cell activation
2001
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
1998
Identification of NKp80, a novel triggering molecule expressed by human NK cells
2001
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
2010 StandoutNature
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein
2002
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells
1999
Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
1999
Mutations Designed to Destabilize the Receptor-Bound Conformation Increase MICA-NKG2D Association Rate and Affinity
2007 StandoutNobel
Natural killer cells, viruses and cancer
2001
miR-15a/16 Regulates Macrophage Phagocytosis after Bacterial Infection
2014
NK CELL RECOGNITION
2004 Standout
Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity
1998
UL40-mediated NK evasion during productive infection with human cytomegalovirus
2002
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
1998
X-Linked Lymphoproliferative Disease
2000
Protein tyrosine phosphatases
2002
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters
2003
Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity
2003
Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis
2000
NK CELL RECEPTORS
1998 Standout
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells
2001
Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family
2001
NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily
1999
Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements
2001
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
Structure and Function of Natural Killer Cell Receptors: Multiple Molecular Solutions to Self, Nonself Discrimination
2002
Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function
2011 StandoutNobel
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
2002
Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
2003
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes
2002
Structure and Function of Natural Killer Cell Surface Receptors
2003
Plasticity in the organization and sequences of human KIR/ILT gene families
2000
Gntb-A, a Novel Sh2d1a-Associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected B Cells in X-Linked Lymphoproliferative Disease
2001
T-Independent Immune Response: New Aspects of B Cell Biology
2000 StandoutScienceNobel
Lipopolysaccharide or Whole Bacteria Block the Conversion of Inflammatory Monocytes into Dendritic Cells In Vivo
2003 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells
1999
2B4 Is Constitutively Associated with Linker for the Activation of T Cells in Glycolipid-Enriched Microdomains: Properties Required for 2B4 Lytic Function
2002
Immunobiology of Dendritic Cells
2000 Standout
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
2012
Decoding the Patterns of Self and Nonself by the Innate Immune System
2002 StandoutScience
Viral Subversion of the Immune System
2000
The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns
2001
Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein
2003
Human natural killer cells
2008
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner
2002
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
Structural basis for simultaneous recognition of anO-glycan and its attached peptide of mucin family by immune receptor PILRα
2014
FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells
2000
Biochemical Nature and Cellular Distribution of the Paired Immunoglobulin-like Receptors, PIR-A and PIR-B
1999
Viral Strategies of Immune Evasion
1998 Science
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells
1999
Activation of Natural Killer Cells and Dendritic Cells upon Recognition of a Novel CD99-like Ligand by Paired Immunoglobulin-like Type 2 Receptor
2004
Tolerogenic Dendritic Cells
2003 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis
2005
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
1999
Identification and Molecular Cloning of P75/Airm1, a Novel Member of the Sialoadhesin Family That Functions as an Inhibitory Receptor in Human Natural Killer Cells
1999
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Place Cells and Place Recognition Maintained by Direct Entorhinal-Hippocampal Circuitry
2002 StandoutScienceNobel
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoingin vitrodifferentiation
2002
The immune response in autism: a new frontier for autism research
2006
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40
2000 Science
Immune Inhibitory Receptors
2000 Science
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel
Works of Luís Borges being referenced
Autoantibody repertoires to brain tissue in autism nuclear families
2004
MECP2 coding sequence and 3′UTR variation in 172 unrelated autistic patients
2007
Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers
1999
LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells
2000
LILRA2 Selectively Modulates LPS-Mediated Cytokine Production and Inhibits Phagocytosis by Monocytes
2012
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
2011
Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48
1999
The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes
1998
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
1997
The leukocyte immunoglobulin-like receptors (LIRs): a new family of immune regulators
1999
A Diversity of Antibody Epitopes Can Induce Signaling through the Erythropoietin Receptor
2010
Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition
2004
A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.
1997
Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo
1999